Oct 14, 2026 · 7 min
Listen from 5:31
Listen at 5:31
AI demand lifts ASML as wind and skincare bets falter
ASML Rises, Orsted Drops, Galderma Slips
The episode connects market moves in technology, renewable energy, and healthcare with the longer-term challenge of planning smarter cities amid rapid urbanization.
- 1ASML rises as sustained AI demand strengthens expectations for chipmaking equipment and expanded production.
- 2Ørsted falls amid legal uncertainty surrounding its Revolution Wind offshore project.
- 3Galderma slips after announcing a $1.5 billion acquisition of Zo Skin Health to expand U.S. medical-grade skincare.
Don't miss
ASML’s rise, set against Ørsted’s decline and Galderma’s slip, creates a compact snapshot of how different strategic risks and opportunities shape European stocks.
The brief
ASML rises on expectations that AI-driven demand for chipmaking equipment will remain strong, while plans to expand production reinforce the market’s confidence in the semiconductor cycle.
Ørsted moves the other way as legal uncertainty surrounds its Revolution Wind project, showing how regulatory risk can weigh on renewable-energy ambitions and investor sentiment.
Galderma slips after announcing its $1.5 billion acquisition of Zo Skin Health, a deal aimed at expanding its medical-grade skincare business in the United States.
The episode then turns to smarter cities, asking how artificial intelligence and long-term planning can help infrastructure keep pace with rapid urbanization, with Dubai as a key example.
Economy of Scale brings the market snapshot into a broader debate about whether innovation can make urban growth more manageable rather than simply more crowded.